ArticleArthroscopy techniques2025
Arthroscopic Autologous Minced Cartilage Implantation for Degenerative Medial Femoral Condyle Lesions of the Knee.
Article in Arthroscopy techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Arthroscopic Autologous Minced Cartilage Implantation for Subchondral Insufficiency Fracture of the Knee.Arthroscopy techniques · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Degenerative cartilage lesions of the knee have been increasingly diagnosed in the population, with a multitude of treatment options available. This article describes an arthroscopic single-stage minced cartilage implantation technique for the treatment of degenerative medial femoral condyle cartilage lesions. The technique involves arthroscopic debridement of the cartilage lesion, microfracture of the subchondral bone, harvesting healthy cartilage from nonweightbearing surfaces, mixing the minced cartilage with autologous platelet-rich plasma, and applying this biological composite to the lesion before sealing it with commercial fibrin glue. The advantages of this approach include its single-stage nature, avoidance of cell culture requirements, and readily available autologous chondrocytes. This technique provides a cost-effective, minimally invasive solution for treating degenerative cartilage lesions in patients seeking to avoid or delay more complex reconstructive procedures or joint replacement surgery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.